Benitec Biopharma Inc. (BNTC) earnings
BNTC earnings moved a median of +1.65% by the close. Quarterly and annual BNTC reports and results, each read against the price at its own news timestamp. Back to the BNTC overview →
23 measured BNTC earnings events.
Where these BNTC earnings landedvs 23 measured BNTC earnings reactions
| Middle 50% of BNTC earnings reactions | -2.02% to +3.59% |
|---|---|
| Median reaction (to close) | +1.65% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 BNTC earnings events with a measured close landed between -2.02% and +3.59%; 65% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Benitec Biopharma Inc. For: Jun 30 | SEC filing · Form 10-K | +3.66% | -9.98% | |
| Form 10-K Benitec Biopharma Inc. For: Jun 30 | SEC filing · Form 10-K | +0.00% | -8.75% | |
| Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update | Press release | +0.00% | +2.60% | |
| Form 10-Q Benitec Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.60% | |
| Form 10-K/A Benitec Biopharma Inc. For: Jun 30 | SEC filing · Form 10-K | +0.89% | -0.53% | |
| Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update | Press release | +0.00% | -2.99% | |
| Form 10-Q Benitec Biopharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -2.99% | |
| Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update | Press release | -2.55% | +1.65% | |
| Form 10-Q Benitec Biopharma Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.55% | +1.65% | |
| Form 10-K Benitec Biopharma Inc. For: Jun 30 | SEC filing · Form 10-K | +0.00% | -1.05% | |
| Benitec Biopharma Releases Third Quarter 2025 Financial Results | Press release | +1.93% | +5.03% | |
| Form 10-Q Benitec Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.93% | +5.03% | |
| Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update | Press release | +2.94% | +10.29% | |
| Form 10-Q Benitec Biopharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +2.94% | +10.29% | |
| Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update | Press release | +0.00% | +3.59% | |
| Form 10-Q Benitec Biopharma Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +3.59% | |
| Form 10-K Benitec Biopharma Inc. For: Jun 30 | SEC filing · Form 10-K | +1.22% | +7.08% | |
| Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update | Press release | -0.11% | -4.58% | |
| Form 10-Q Benitec Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.11% | -4.58% | |
| Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update | Press release | +0.00% | +1.47% | |
| Form 10-Q Benitec Biopharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +1.47% | |
| Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update | Press release | — | +2.98% | |
| Form 10-Q Benitec Biopharma Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +2.98% |
Keep exploring
More BNTC: analyst actions → · SEC filings → · BNTC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OptiNose, Inc. (OPTN) | 205 | 0.00% | 48% |
| ASPEN PHARMACRE HL UN/ADR (APNHY) | 204 | 0.00% | 15% |
| Immuron Limited - American Depositary Shares (IMRN) | 202 | -0.21% | 29% |
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.